Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

Clinical trial NCT07710885 · RECRUITING

Trial details

NCT number: NCT07710885
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2026-06-24
Primary completion: 2030-04-30
Enrollment: 784

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.